Manifold MarketsSem KYCDados de resolução verificadosRazoavelmente calibradoAviso de qualidade dos dadosDados da fonte degradados
Dados de 26 de out. de 2026, 05:51 UTC · política pm-quality-4
Previsão da comunidade atualNão 90.8%
Previsores
16
Tipo de pergunta
binary
Metodologia
Play-money forecasting platform
Tipo de fonte
Previsão
Dados do mercado
Atualizado há 3 horas
Desatualizado21/02/23, 20:26 UTC31/12/27, 22:59 UTC
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
Will FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiRegras
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of malaria in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
